<DOC>
	<DOCNO>NCT00306215</DOCNO>
	<brief_summary>The purpose study determine whether CCX282-B effective treating patient moderate severe Crohn 's Disease .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety CCX282-B Subjects With Moderate Severe Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Key moderate severe Crohn 's Disease CDAI 250450 CRP &gt; 7.5 sign write informed consent Key &gt; 100 cm small bowel resect ileostomy , colostomy rectal pouch diagnosis ulcerative colitis indeterminate colitis evidence short bowel syndrome require enteral parenteral supplementation total parenteral nutrition hepatitis B , C HIV infection history infection require IV antibiotic serious GI infection previous 12 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>double-blind</keyword>
	<keyword>placebo-controlled</keyword>
	<keyword>multicenter</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
</DOC>